Journal
CANCER CELL
Volume 11, Issue 4, Pages 349-360Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2007.02.015
Keywords
-
Categories
Funding
- NCI NIH HHS [P01 CA078378, R01 CA050947, U01 CA084313] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [P01CA078378, U01CA084313, R01CA050947] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Multiple myeloma. (MM) evolves from a highly prevalent premalignant condition termed MGUS. The factors underlying the malignant transformation of MGUS are unknown. We report a MGUS/MM phenotype in transgenic mice with E mu-directed expression of the XBP-1 spliced isoform (XBP-1 s), a factor governing unfolded protein/ER stress response and plasma-cell development. E mu-XPB-1s elicited elevated serum Ig and skin alterations. With age, E mu-xbp-ls transgenics develop features diagnostic of human MM, including bone lytic lesions and subendothelial Ig deposition. Furthermore, transcriptional profiles of E mu-xbp-1s lymphoid and MM cells show aberrant expression of known human MM dysregulated genes. The similarities of this model with the human disease, coupled with documented frequent XBP-1 s overexpression in human MM, serve to implicate XBP-1 s dysregulation in MM pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available